The design of a prodrug to utilise the thymidine phosphorylase enzyme
The current study has investigated the design of a prodrug to utilise the thymidine phosphorylase enzyme, based on combining HPMA copolymer technology with a thymidine analogue to deliver 5-fluorouracil or other cytotoxic agents selectivity to cancer tumours. A detailed review has been compiled cov...
| Main Author: | |
|---|---|
| Published: |
University of Aberdeen
2003
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.400668 |